NCT07349862

Brief Summary

This study aims to examine the effects of cancer screening training, conducted using a ChatGPT-based flipped learning model, on knowledge, learning motivation, and class participation.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2025

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

December 22, 2025

Last Update Submit

January 16, 2026

Conditions

Keywords

learning motivationclassroom engagementflipped learningChatGPT

Outcome Measures

Primary Outcomes (1)

  • Cancer Screening Knowledge Scale

    This scale consists of 25 items and 3 sub-dimensions. The sub-dimensions are not specifically named. The first sub-dimension contains 10 items (items 8, 17-23, 25, 28), the second sub-dimension contains 9 items (items 4, 5, 7, 10, 12, 13, 15, 16, 27), and the third sub-dimension contains 6 items (items 1-3, 9, 11, 24). The scale is a three-point rating scale. The scale is answered on a scale of 1 to 3, with "1: True, 2: False, 3: I don't know". When calculating the scale score, "True" answers are worth 1 point, and "False" and "I don't know" answers are worth 0 points. The lowest possible score on the scale is 0, and the highest is 25. When calculating the scale score, the three items with negative connotations (Items 2, 11, 24) should be reverse-coded. The order of the items on the scale is not important; researchers may use a mixed order. There is no cutoff point for the scale score.

    4 weeks

Secondary Outcomes (1)

  • Learning Motivation Scale in Higher Education

    4 weeks

Other Outcomes (1)

  • Classroom Engagement Scale

    4 weeks

Study Arms (2)

Intervention group- ChatGPT Flipped Learning

EXPERIMENTAL

ChatGPT-Based Flıpped Learnıng Model

Other: ChatGPT-Based Flıpped Learning Model

Control Group- Traditioanl Flipped Learning

PLACEBO COMPARATOR

Traditional Flıpped Learnıng Model

Other: Traditional Flıpped Learning Model

Interventions

Training group based on traditional flipped learning model

Control Group- Traditioanl Flipped Learning

Training group based on ChatGPT-based flipped learning model

Intervention group- ChatGPT Flipped Learning

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Students who have taken courses in fundamentals of nursing, internal medicine nursing, physiology, pathology, and computer science, but have not taken a course in oncology nursing,
  • Third-year students,
  • Those who have voluntarily agreed to participate in the study.

You may not qualify if:

  • Students who were not third-year students,
  • Those who had not taken one of the following courses: fundamentals of nursing, internal medicine nursing, physiology, pathology, computer science, oncology nursing,
  • Those who did not volunteer to participate in the research were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tekirdag Namık Kemal University

Tekirdağ, Suleymanpasa, 59030, Turkey (Türkiye)

Location

Study Officials

  • DİLEK ERDEN

    Namik Kemal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Assistant Professor (Dr.)

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 20, 2026

Study Start

December 1, 2025

Primary Completion

January 30, 2026

Study Completion

February 15, 2026

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

I can share it with researchers who request it for reasonable reasons.

Locations